REBLOZYL is a prescription medicine used to treat anemia (low red blood cells) in adults with myelodysplastic syndromes with ring sideroblasts (MDS‑RS) or myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN‑RS‑T) who need regular RBC transfusions and have not responded well to or cannot receive an erythropoiesis stimulating agent (ESA).
REBLOZYL is not for use as a substitute for RBC transfusions in people who need immediate treatment for anemia.
It is not known if REBLOZYL is safe or effective in children.
REBLOZYL is the first and only erythroid maturation agent
REBLOZYL is called an erythroid maturation agent because it helps erythroid cells develop and become mature, working red blood cells. This may result in a greater number of healthy red blood cells and improve anemia.